
|Articles|June 1, 2004
Off-label uses broaden as derms explore Botox
Washington - The number of potential dermatologic uses for botulinum toxin type A (Botox Cosmetic) continues to increase, but the already sizable list probably only represents the tip of the iceberg, says Seth L. Matarasso, M.D., at the annual meeting of the American Academy of Dermatology
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
3
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
4
Digital Twins in Dermatology: Your Patient’s Virtual Double Is Coming
5














